Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC
A phase 3 trial of Envafolimab, Gemcitabine and Oxaliplatin in biliary tract cancer, run by 3D Medicines (Sichuan) Co., Ltd., active and no longer recruiting.
Overview
Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC is a phase 3 interventional study registered as NCT03478488 by 3D Medicines (Sichuan) Co., Ltd., with 480 participants enrolled, started 2018-04-16 and due to reach its primary completion in 2024-09-10. Interventions recorded: KN035 plus Gemcitabine & oxaliplatin and Gemcitabine & oxaliplatin.
Similar pages
not linked directly; found by shared links- TrialCosiporfin Sodium for Injection Photodynamic Therapy
Shares Gemcitabine, Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
- TrialDurvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)
Shares Oxaliplatin, Gemcitabine, Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
- TrialKN035 for dMMR/MSI-H Advanced Solid Tumors
Shares Envafolimab and the tag pipeline.
- TrialENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
Shares Envafolimab and the tag pipeline.
- TrialA Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)
Shares Oxaliplatin, Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
- TrialA Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
Shares Oxaliplatin, Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
- TrialIrinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer
Shares Oxaliplatin, Gemcitabine and the tag pipeline.
- TrialClinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
Shares Oxaliplatin, Gemcitabine and the tag pipeline.